サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1716972

内視鏡的逆行性胆管膵管造影（ERCP）の世界市場レポート 2025年

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
内視鏡的逆行性胆管膵管造影（ERCP）の世界市場レポート 2025年
出版日: 2025年04月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

内視鏡的逆行性胆管膵管造影（ERCP）市場規模は、今後数年で力強い成長が見込まれます。2029年にはCAGR8.58％で26億米ドルに成長します。この期間の成長予測は、消化器疾患の有病率の上昇、がんの罹患率の上昇、投資の焦点の高まり、膵管疾患の発生率の上昇、内視鏡の需要の高まりによってもたらされます。主な動向としては、技術の進歩、研究開発のためのパートナーシップ、ヘルスケアインフラの拡大、政府のヘルスケアイニシアチブの増加、先進的なERCP製品の開発などが予想されます。

胃腸疾患の有病率の上昇は、内視鏡的逆行性胆管膵管造影（ERCP）市場の成長を促進すると予測されています。これらの疾患は、口、食道、胃、腸、直腸、肛門、および肝臓、胆嚢、膵臓などの付属臓器を含む消化管（GI）に影響を及ぼす幅広い疾患を包含します。食生活の変化、高齢化、抗生物質の使用、生活習慣、環境の影響などの要因が、これらの疾患の発生率を高めています。ERCPは、胆石、狭窄、腫瘍、感染症などの胆管・膵管の問題を診断・治療するための低侵襲なソリューションです。例えば、米国がん学会は2024年1月に、米国で新たに胃がんの症例が約2万6,890件発生し、約1万880人が死亡すると推定しています。胃腸疾患が一般的になるにつれ、ERCP手技の需要は増加の一途をたどっています。

ERCP市場の各社は、診断と治療を強化するために胆管鏡システムなどの革新的な技術を開発し、手技を進歩させています。これらのシステムは、胆管や膵管の高解像度画像を提供し、治療成績を向上させる。2024年7月、ペンロンリミテッドは、ERCP手技のための正確なイメージングを提供する最先端の装置であるVedVision胆管鏡直接可視化システムを発表しました。このシステムには、2mmのアクセサリーチャンネルと専用のガイドワイヤーチャンネル、生検鉗子、結石摘出バスケット、細胞診ブラシ、ポリープ切除スネアなどのアクセサリーが含まれ、診断と治療の能力を向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界内視鏡的逆行性胆管膵管造影（ERCP） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：成長率分析
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場の実績：規模と成長, 2019-2024
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場の予測：規模と成長, 2024-2029, 2034F
  • 世界内視鏡的逆行性胆管膵管造影（ERCP）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 内視鏡
  • 内視鏡治療装置
  • 可視化システム
  • エネルギーデバイス
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：疾患適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 胃食道逆流症（GERD）
  • 消化器がん
  • バレット食道
  • 胆管疾患
  • 消化性潰瘍
  • クローン病
  • 腸偽閉塞
  • オギルビー症候群
  • その他の適応症
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 胆道括約筋切開術
  • 胆道拡張症
  • 胆管ステント留置術
  • 膵括約筋切開術
  • 膵管拡張
  • 膵管ステント留置術
  • その他の用途
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院と診療所
  • 外来手術センター
  • その他のエンドユーザー
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場内視鏡の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • フレキシブル内視鏡
  • 半硬性内視鏡
  • 高解像度内視鏡
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場、タイプ別内視鏡治療機器のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 結石除去装置
  • バルーン拡張カテーテル
  • ステント
  • 生検鉗子
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場可視化システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 高解像度可視化システム
  • 内視鏡画像システム
  • ビデオ内視鏡
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場エネルギー機器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 電気外科用機器
  • レーザーデバイス
  • アルゴンプラズマ凝固システム

第7章 地域別・国別分析

  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 内視鏡的逆行性胆管膵管造影（ERCP）市場：競合情勢
  • 内視鏡的逆行性胆管膵管造影（ERCP）市場：企業プロファイル
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • B. Braun Melsungen AG
  • Olympus Corporation
  • Ottomed Endoscopy
  • W. L. Gore & Associates Inc.
  • Streis plc
  • Cook Group
  • KARL STORZ SE & Co. KG
  • CONMED Corporation
  • PENTAX Medical Inc.
  • AMBU Inc.
  • Samsung Medison Co. Ltd.
  • Medi-Globe GmbH
  • Telemed System Inc.
  • Micro-Tech Endoscopy Inc.
  • Hobbs Medical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 内視鏡的逆行性胆管膵管造影（ERCP）市場2029：新たな機会を提供する国
  • 内視鏡的逆行性胆管膵管造影（ERCP）市場2029：新たな機会を提供するセグメント
  • 内視鏡的逆行性胆管膵管造影（ERCP）市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33700

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth during the historical period can be attributed to the increasing prevalence of chronic gastrointestinal diseases, expanded applications of ERCP, a rising incidence of pancreatic cancer, growing government investments, and an increase in medical tourism.

The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth forecast for this period is driven by the rising prevalence of gastrointestinal conditions, an increasing incidence of cancer, heightened investment focus, a growing occurrence of pancreatic duct conditions, and rising demand for endoscopes. Key trends expected include technological advancements, partnerships for research and development, the expansion of healthcare infrastructure, increased government healthcare initiatives, and the development of advanced ERCP products.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
  • 2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett's Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn's Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
  • 3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
  • 4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
  • 2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
  • 3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
  • 4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
  • Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growth Rate Analysis
  • 5.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Total Addressable Market (TAM)

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

  • 6.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • 6.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastroesophageal Reflux Disease (GERD)
  • Gastrointestinal Cancer
  • Barrett's Esophagus
  • Bile Duct Diseases
  • Peptic Ulcer Disease
  • Crohn's Disease
  • Intestinal Pseudo-Obstruction
  • Ogilvie Syndrome
  • Other Indications
  • 6.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting
  • Other Applications
  • 6.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Endoscopes
  • Semi-Rigid Endoscopes
  • High-Resolution Endoscopes
  • 6.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endotherapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stone Extraction Devices
  • Balloon Dilatation Catheters
  • Stents
  • Biopsy Forceps
  • 6.7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Visualization Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Definition Visualization Systems
  • Endoscopic Imaging Systems
  • Video Endoscopes
  • 6.8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Energy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrosurgical Devices
  • Laser Devices
  • Argon Plasma Coagulation Systems

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

  • 7.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 8.1. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 9.1. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 9.2. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 10.1. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 11.1. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 11.2. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 12.1. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 13.1. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 14.1. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 14.2. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 15.1. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 15.2. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 16.1. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 17.1. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 18.1. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 19.1. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 20.1. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 21.1. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 21.2. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 22.1. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 23.1. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 23.2. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 24.1. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 24.2. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 25.1. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 25.2. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 26.1. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 26.2. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 27.1. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 28.1. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 28.2. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 29.1. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 29.2. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

  • 30.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape
  • 30.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Olympus Corporation
  • 31.3. Ottomed Endoscopy
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Streis plc
  • 31.6. Cook Group
  • 31.7. KARL STORZ SE & Co. KG
  • 31.8. CONMED Corporation
  • 31.9. PENTAX Medical Inc.
  • 31.10. AMBU Inc.
  • 31.11. Samsung Medison Co. Ltd.
  • 31.12. Medi-Globe GmbH
  • 31.13. Telemed System Inc.
  • 31.14. Micro-Tech Endoscopy Inc.
  • 31.15. Hobbs Medical Inc.

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

  • 35.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer